SKS Ocular Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

SKS Ocular General Information

Description

Operator of a biopharmaceutical company. The company is developing a sustained-release technology platform to develop drug formulations for ocular disease. The platform employs micro fabrication techniques to create nano and microparticle drug formulations that can provide sustained and predictable release of a therapeutic drug over a 3 - 6 month period. The company has four active pipelines under way in glaucoma, steroid-induced glaucoma, allergic conjunctivitis and protein delivery.

Contact Information

Website
www.sksocular.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5871 Oberlin Drive
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Ohr Pharmaceutical
Corporate Office
  • 5871 Oberlin Drive
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SKS Ocular Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SKS Ocular‘s full profile, request access.

Request a free trial

SKS Ocular Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

SKS Ocular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014047477-A2 Multilayer biodegradable microparticles for sustained release of therapeutic agents Inactive 20-Sep-2012
WO-2014047477-A3 Multilayer biodegradable microparticles for sustained release of therapeutic agents Inactive 20-Sep-2012

SKS Ocular FAQs

  • When was SKS Ocular founded?

    SKS Ocular was founded in 2010.

  • Where is SKS Ocular headquartered?

    SKS Ocular is headquartered in San Diego, CA.

  • What industry is SKS Ocular in?

    SKS Ocular’s primary industry is Drug Delivery.

  • Is SKS Ocular a private or public company?

    SKS Ocular is a Private company.

  • What is SKS Ocular’s current revenue?

    The current revenue for SKS Ocular is .

  • When was SKS Ocular acquired?

    SKS Ocular was acquired on 15-May-2014.

  • Who acquired SKS Ocular?

    SKS Ocular was acquired by Ohr Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process